Recce Pharmaceuticals
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Salesforce Tower 180 George St L 23, Syd...Phone Number
+61 292562505Website
www.recce.com.auRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Recce Pharmaceuticals
Recce Pharmaceuticals, founded in 2007 and headquartered in Australia, is a pharmaceutical manufacturing company developing synthetic anti-infective medications. The company focuses on addressing global health challenges related to antibiotic-resistant superbugs and emerging viral pathogens. Recce maintains automated manufacturing facilities to support its ongoing clinical trials. The company's product pipeline targets unmet medical needs through its proprietary technologies. As a publicly traded company with multiple global locations, Recce Pharmaceuticals serves the business-to-business market within the healthcare and pharmaceutical industries.Explore more
Recce Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Recce Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Recce Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Recce Pharmaceuticals has new funding data
Recce Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Recce Pharmaceuticals
Check out if Recce Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Recce Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Recce Pharmaceuticals launches new products
Check if Recce Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Recce Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Recce Pharmaceuticals
Compare insights from companies similar to Recce Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Recce Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Recce Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Recce Pharmaceuticals.
Recce Pharmaceuticals financials insights
Gather financial insights about Recce Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Share Placement
$11M
2024
Grant
$2M
Recce Pharmaceuticals Tech Stack
A closer look at the technologies used by Recce Pharmaceuticals
Most Recent Scoops
Project
Product Development, Product Management, Legal Affairs, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Project
Product Development, Product Management, Legal Affairs, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Funding
Funding
Event
Events
Project
Research & Development, Product Management, Intellectual Property, Legal Affairs
Recce Pharmaceuticals News & Media
Recce Pharmaceuticals gains key approval to advance diabetic foot infection trial to pivotal Phase 3
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has secured Human Research Ethics Committee (HREC) approval to advance its Australian clinical trial of RECCE® 327 Topical Gel (R327G) for diabetic foot infections (DFI) to a pivotal Phase 3 study, marking a key step in the company’s global...Recce Pharmaceuticals advances US Army burn wound program and Indonesia Phase 3 trial in March quarter
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has reported Q3 FY2026 operational progress across its anti-infective pipeline, led by a second US Army research agreement, continued dosing in its Indonesian Phase 3 trial and expanded patent protection in Brazil. US Army collaboration...Inside Biotech: Recce Pharmaceuticals advances late-stage push in antibiotic resistance fight
Antibiotic resistance is tightening its grip on global healthcare, but the pipeline of truly new treatments remains thin. That imbalance — rising need, limited innovation — has become a defining theme in infectious disease biotech. And it’s one that Recce Pharmaceuticals Ltd (ASX:RCE,...Recce Pharmaceuticals Insiders Placed Bullish Bets Worth AU$6.19m
Over the last year, a good number of insiders have significantly increased their holdings in Recce Pharmaceuticals Ltd...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Recce Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Recce Pharmaceuticals, founded in 2007 and headquartered in Australia, is a pharmaceutical manufacturing company developing synthetic anti-infective medications. The company focuses on addressing global health challenges related to antibiotic-resistant superbugs and emerging viral pathogens. Recce maintains automated manufacturing facilities to sup... Read More
